CN101912547A - Medicament for treating dizziness and preparation method thereof - Google Patents
Medicament for treating dizziness and preparation method thereof Download PDFInfo
- Publication number
- CN101912547A CN101912547A CN 201010264651 CN201010264651A CN101912547A CN 101912547 A CN101912547 A CN 101912547A CN 201010264651 CN201010264651 CN 201010264651 CN 201010264651 A CN201010264651 A CN 201010264651A CN 101912547 A CN101912547 A CN 101912547A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- processed
- zingiberis recens
- rhizoma zingiberis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating dizziness, which is characterized by being prepared from the following raw materials in part by weight: 1 to 20 parts of rose, 1 to 20 parts of seville orange flower, 1 to 20 parts of ginger-processed bamboo shavings, 1 to 20 parts of ginger-processed pinellia, 1 to 20 parts of dried tangerine peel, 1 to 20 parts of Indian buead, 1 to 20 parts of mix-fried licorice, 1 to 20 parts of immature bitter orange, 1 to 20 parts of dried kudzuvine root, 1 to 20 parts of salvia, 1 to 20 parts of uncaria, 1 to 20 parts of raw magnetite and 1 to 20 parts of over 95 percent edible alcohol. The medicament can be absorbed through spleen and stomach by oral administration and absorbed through skin by external use, and can be compositely absorbed in a mode of combining the oral administration and external use. The medicament has the advantages of reasonable formula, simplified components, exact curative effect and treatment for both principal and secondary aspect of the disease. The invention also provides a method for preparing the medicament.
Description
Technical field
The invention belongs to the field of Chinese medicines, medicine that the treatment of particularly a kind of oral administration or external is dizzy and preparation method thereof.
Background technology
Dizzy is dizzy and dizzy general name, is dizzy with dim eyesight, blurring of vision and dim blackout; Looking thing rotation, or as very dizzy can not standing to dizzy, simultaneously normal and see because of both, so title is dizzy.Dizzy is that a kind of motion discipline is felt or illusion of movement, is directed sensory disturbance or the para equilibrium of patient for spatial relationship, and the patient feels external environment or from rotating, move or rocking, caused by the vestibular nervous system pathological changes.
Cause that dizzy kinds of Diseases are a lot, nearly hundreds of disease can cause that the reason of dizzy, different disease also is different.According to the difference of diseased region, roughly can be divided into peripheral vertigo and central vertigo two big classes.Central vertigo is to be caused by cerebral tissue, cranial nerve diseases, such as acoustic neuroma, cerebrovascular disease etc., accounts for 30% of dizzy patient's sum.Peripheral vertigo accounts for 70%, and most peripheral vertigos are relevant with our ear disease.In peripheral vertigo when outbreak, is many with cochlea symptom (change of audition, tinnitus) and autonomic nervous system symptom such as feel sick, vomit, be in a cold sweat.But part disease repeated relapsing is dizzy, spontaneous remission.
Chinese patent CN200410074042.6 discloses a kind of treatment dizziness Chinese medicine preparation, by Rhizoma Alismatis, and the Rhizoma Atractylodis Macrocephalae, Poria, Pericarpium Citri Reticulatae, the Rhizoma Pinelliae, Fructus Ligustri Lucidi, Herba Ecliptae, Flos Chrysanthemi, Radix Achyranthis Bidentatae, Radix Glycyrrhizae is processed into tablet and granule.Chinese patent CN03121265.4 discloses a kind of dizzy Chinese medicine for the treatment of, and makes oral liquid, granule or capsule by medical materials such as the Radix Astragali, Folium Ginkgo, Radix Salviae Miltiorrhizae, Herba Agrimoniae, Fructus Lycii, Semen Cuscutae, Fructus Schisandrae Chinensis, Fructus Ligustri Lucidi, Radix Puerariaes.Chinese patent CN200510038858.8 discloses a kind of dizzy multiple quiet capsule of dizzy Chinese medicine compound for the treatment of, and its raw material is made up of Semen Strychni (processed), Margarita, Folium Et Cacumen Murrayae, Bombyx Batryticatus (parched) four Chinese medicine.
The Chinese medicine product that above-mentioned treatment is dizzy is paid attention to regulating too much, has reduced the medicine proportion of a therapeutical effect relatively, has influenced the pharmic function performance, so effect is slow, the course of treatment is long, and effect is undesirable; And existing Chinese medicine oral administration but can not external, but can not the taking orally again of external, route of administration is single, makes the patient slow to the absorption of medicine.Chinese medicine for oral administration not only absorbs slowly, and causes spleen injury easily, even increase the weight of the state of an illness for the patient of weakness of the spleen and stomach.
Chinese medicine is taken difficulty owing to mostly be decoction or the pill that boils than Western medicine, has also influenced the popularization of Chinese medicine widely.
Summary of the invention
The objective of the invention is to overcome the defective that prior art exists, a kind of reasonable recipe is provided, compatibility is simplified, the dizzy medicine of treatment of determined curative effect, treating both the principal and secondary aspects of a disease, to control, control foster combination, and this medicine can take orally by taste absorb again can external by skin absorbs, can also oral administration and externally used dual mode composite absorption.This compound administering mode helps the efficient absorption of human body to medicine, and for the crowd of weakness of the spleen and stomach, the medicine that is busy with one's work, spares oneself provides multiple choices, especially the patient by the modern job crowd is accepted.
Technical scheme of the present invention is as follows:
A kind ofly treat dizzy medicine, it is characterized in that it mainly is to be made by the raw material of following weight portion: 1 ~ 20 part of Flos Rosae Rugosae, 1 ~ 20 part of CitrusaurantiumL.Var.amara Engl., 1 ~ 20 part of Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), 1 ~ 20 part of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), 1 ~ 20 part of Pericarpium Citri Reticulatae, 1 ~ 20 part in Poria, 1 ~ 20 part of Radix Glycyrrhizae Preparata, 1 ~ 20 part of Fructus Aurantii Immaturus, 1 ~ 20 part of Radix puerariae root, 1 ~ 20 part of Radix Salviae Miltiorrhizae, 1 ~ 20 part of Ramulus Uncariae macrophyllae, 1 ~ 20 part of Magnetitum, content are 1 ~ 20 part of edible ethanol more than 95%.
Further, the consumption of each component of medicine of the present invention is: 15 ~ 20 parts of Flos Rosae Rugosaes, 15 ~ 20 parts of CitrusaurantiumL.Var.amara Engl.s, 15 ~ 20 parts of Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), 15 ~ 20 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 15 ~ 20 parts of Pericarpium Citri Reticulataes, 15 ~ 20 parts in Poria, 15 ~ 20 parts of Radix Glycyrrhizae Preparatas, 5 ~ 10 parts of Fructus Aurantii Immaturuss, 15 ~ 20 parts of Radix puerariae roots, 15 ~ 20 parts of Radix Salviae Miltiorrhizae, 15 ~ 20 parts of Ramulus Uncariae macrophyllae, 15 ~ 20 parts of Magnetitum, content are 15 ~ 20 parts of edible ethanols more than 95%.
The middle survival dose of above compatibility is the crude drug amount.
In order to strengthen the transdermal effect of medicine, can also mix transdermal agent in the medicine of the present invention, preferably weight portion is 1 ~ 5 part a azone.
Another object of the present invention provides manufacturing method for above mentioned medicine, it is characterized in that comprising the following steps:
A) take by weighing Flos Rosae Rugosae, CitrusaurantiumL.Var.amara Engl., Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), Pericarpium Citri Reticulatae, Poria, Radix Glycyrrhizae Preparata, Fructus Aurantii Immaturus, Radix puerariae root, Radix Salviae Miltiorrhizae, Ramulus Uncariae macrophyllae and the Magnetitum of described weight proportion, according to the conventional extracting method of Chinese medicine, the extract of the former medicine that obtains respectively respectively to distinguish the flavor of;
B) under the room temperature, get the deionized water of 5 ~ 6 times of amounts, the content that adds described weight proportion is the edible ethanol more than 95%, is mixed with aqueous solution of alcohol;
C) with in the above-mentioned aqueous solution of alcohol of the extract obtained adding of step a, stirred 120 minutes, precipitate 2 ~ 4 hours, filter, gained filtrate sterilization, fill according to quantity must be treated dizzy medicine.
Further, among the step c, can add in the aqueous solution of alcohol together by azone step a is extract obtained and 1 ~ 5 weight portion.
The conventional extracting method of described Chinese crude drug can adopt decocting method, circumfluence method, infusion process, percolation, semi-bionic extraction, supercritical fluid extraction, microwave extraction method etc. according to the kind of medical material.
Cause dizzy reason always more wind, fire, expectorant, the stasis of blood, empty five words, deficiency in origin and excess in superficiality, deficiency and excess is held under the arm assorted, and its stage of attack, mostly be the disease of this slow mark urgency.
The present invention is directed to dizzy characteristics, select Flos Rosae Rugosae, CitrusaurantiumL.Var.amara Engl., Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), Pericarpium Citri Reticulatae, Poria, Radix Glycyrrhizae Preparata, Fructus Aurantii Immaturus, Radix puerariae root, Radix Salviae Miltiorrhizae, Ramulus Uncariae macrophyllae, Magnetitum for use, with being that edible ethanol more than 95% mixes with content after each flavor Chinese medicine extraction, make to contain pure Chinese medicine extraction liquid.Employing to be to control, and control and support bonded method, but not only also external of oral administration of the medicine of making is a kind of reasonable recipe, and compatibility is simplified, the dizzy medicine of treatment of determined curative effect, treating both the principal and secondary aspects of a disease.
Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens) is regulated the flow of vital energy, stomach function regulating, sending down the abnormal ascending QI.Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) preventing or arresting vomiting, detoxifcation.Appetizing, drying dampness to eliminate phlegm in Pericarpium Citri Reticulatae circulation of qi promoting spleen invigorating, stopping nausea and vomiting by lowering the adverse flow of QI, the accent.The Poria eliminating dampness and diuresis, strengthening the spleen stomach function regulating, mind tranquilizing and the heart calming.The Radix Glycyrrhizae Preparata nourishing YIN and benefiting blood, QI invigorating warming YANG, the multiple arteries and veins of only throbbing with fear.The Fructus Aurantii Immaturus dispelling the stagnated QI, the painful abdominal mass of loosing is rushed down expectorant, removing food stagnancy.Radix puerariae root yang invigorating expelling pathogenic factors from muscles, rash antidiarrheal, relieving restlessness ends temperature.The Radix Salviae Miltiorrhizae promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind.Ramulus Uncariae macrophyllae heat clearing away suppressing the hyperactive liver, dispelling wind and relieving convulsion.The Magnetitum calming down the floating YANG to promote inspiration for relieving dyspnea, tranquillizing the mind by relieving convulsion.
Medicine eliminating phlegm of the present invention is let out fire, is opened and stop up a surname's numbness, lowering the adverse QI to ease the middleJIAO; Join Radix Puerariae, with the lucid yang sending up, association's Radix Salviae Miltiorrhizae is with active; Assistant Ramulus Uncariae Cum Uncis blood vessel dilating increases brain and internal ear hemoperfusion amount, thereby collects the effect that dizzy preventing or arresting vomiting removes rapidly.Flos Rosae Rugosae regulate the flow of vital energy resolving depression and blood dissipating blood stasis; The CitrusaurantiumL.Var.amara Engl. the chest stuffiness relieving of regulating the flow of vital energy, dispersing the stagnated liver-QI for regulating the stomach, appetizing preventing or arresting vomiting.Two medicines, 5 usefulness, a gas one blood, QI and blood is two transfers, and the strength of eliminating turbid pathogen with aromatics, be amusing appetizing, regulating QI to relieve pain strengthens.Content is the edible ethanol blood circulation promoting and blood stasis dispelling more than 95%, promotes that drug osmotic to cell absorbs.
Medicine of the present invention can also be smeared by whole body except for oral administration.Adopt oral administration and externally usedly, drug effect is more remarkable.
It is obvious that the present invention treats dizzy curative effect, short treating period, and can be used for aural vertigo, motion sickness, vertebro-basilar artery insufficiency is the dizzy stage of attack of various repeated relapsings of representative.Clinical usefulness repeatly, effect are very prompt.
Medicine of the present invention is through clinical 70 routine patients' clinical verification, and curing number is 55 examples, and significant figure is 12 examples, and invalid number is 3 examples, and total effective rate reaches 95.7%.Do not see toxic side effect in the therapeutic process, the patient has better curative effect to obstinate.
For further specifying therapeutic effect, it is as follows now to enumerate model case:
Case 1: certain woman, 27 years old, dim eyesight often, blurring of vision, dim blackout, look thing rotation even can not stand.Oral medicine of the present invention, each 10 milliliters, every day 3 times.The dizzy beginning alleviated after 5 days.Adhere to taking dizzy basic elimination after 30 days.Paying a return visit after 6 months does not have recurrence.
Case 2: certain woman, 35 years old, what usually can feel dizzy was dizzy, feels sick, vomits, emits cold sweat.The ill existing several years, once took the dizzy Chinese medicine of a variety of treatments, but effect is all not good.External medicine of the present invention is smeared whole body and head, every day 2 times, each 10 milliliters.External after 5 days dizzy the beginning take a turn for the better.Adhere to taking dizzy basic elimination after 26 days.Paying a return visit after 6 months does not have recurrence.
Case 3: certain man, 55 years old, through dizzy can not the standing that regular meeting feels dizzy, feel sick, vomit, emit cold sweat.Ill existing many decades was once taken the dizzy Chinese medicine of a variety of treatments, but effect is all not good.Oral medicine of the present invention, each 10 milliliters, every day 3 times; This medicine of external is smeared whole body and head, every day 2 times, each 10 milliliters.Oral and external dizzy remarkable alleviation after 3 days.Adhere to using dizzy basic elimination after 20 days, spirit and QI cleaning.Paying a return visit after 9 months does not have recurrence.
The specific embodiment
Embodiment 1
Take by weighing 15 parts of Flos Rosae Rugosaes, 18 parts of CitrusaurantiumL.Var.amara Engl.s, 16 parts of Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), 16 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 16 parts of Pericarpium Citri Reticulataes, 16 parts in Poria, 16 parts of Radix Glycyrrhizae Preparatas, 8 parts of Fructus Aurantii Immaturuss, 16 parts of Radix puerariae roots, 16 parts of Radix Salviae Miltiorrhizae, 16 parts of Ramulus Uncariae macrophyllae, 16 parts of Magnetitum adopt the method that decocts the back concentrating under reduced pressure to make Chinese medicine extract respectively, and are standby.
Under the room temperature, get the deionized water of 5 ~ 6 times of amounts, add content and be 18 parts of 96% edible ethanols, be mixed with aqueous solution of alcohol, standby.
Above-mentioned various Chinese medicine extract are added in the aqueous solution of alcohol, fully stirred 120 minutes, precipitate 2 ~ 4 hours, supernatant 200 orders filter, and the dizzy medicine of treatment that gained filtrate is oral administration or external carries out fill under aseptic condition.Gained precipitate and filtering residue focus on.
Embodiment 2
The drug component proportioning is: 18 parts of Flos Rosae Rugosaes, 19 parts of CitrusaurantiumL.Var.amara Engl.s, 17 parts of Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), 17 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 17 parts of Pericarpium Citri Reticulataes, 17 parts in Poria, 17 parts of Radix Glycyrrhizae Preparatas, 9 parts of Fructus Aurantii Immaturuss, 17 parts of Radix puerariae roots, 17 parts of Radix Salviae Miltiorrhizae, 17 parts of Ramulus Uncariae macrophyllae, 17 parts of Magnetitum, content are 18 parts of 97% edible ethanols.Other is identical with embodiment 1.
Embodiment 3
The drug component proportioning is: 19 parts of Flos Rosae Rugosaes, 20 parts of CitrusaurantiumL.Var.amara Engl.s, 18 parts of Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), 18 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 18 parts of Pericarpium Citri Reticulataes, 18 parts in Poria, 18 parts of Radix Glycyrrhizae Preparatas, 10 parts of Fructus Aurantii Immaturuss, 18 parts of Radix puerariae roots, 18 parts of Radix Salviae Miltiorrhizae, 18 parts of Ramulus Uncariae macrophyllae, 18 parts of Magnetitum, content are 18 parts of 98% edible ethanols.Other is identical with embodiment 1.
Embodiment 4
The drug component proportioning is: 16 parts of Flos Rosae Rugosaes, 17 parts of CitrusaurantiumL.Var.amara Engl.s, 19 parts of Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), 19 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 16 parts of Pericarpium Citri Reticulataes, 18 parts in Poria, 19 parts of Radix Glycyrrhizae Preparatas, 6 parts of Fructus Aurantii Immaturuss, 19 parts of Radix puerariae roots, 16 parts of Radix Salviae Miltiorrhizae, 19 parts of Ramulus Uncariae macrophyllae, 19 parts of Magnetitum, content are 19 parts of 99% edible ethanols.Other is identical with embodiment 1.
Embodiment 5
The drug component proportioning is: 17 parts of Flos Rosae Rugosaes, 18 parts of CitrusaurantiumL.Var.amara Engl.s, 16 parts of Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), 18 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 19 parts of Pericarpium Citri Reticulataes, 19 parts in Poria, 16 parts of Radix Glycyrrhizae Preparatas, 7 parts of Fructus Aurantii Immaturuss, 16 parts of Radix puerariae roots, 17 parts of Radix Salviae Miltiorrhizae, 18 parts of Ramulus Uncariae macrophyllae, 18 parts of Magnetitum, content are 17 parts of 100% edible ethanols.Other is identical with embodiment 1.
Embodiment 6
The drug component proportioning is: 18 parts of Flos Rosae Rugosaes, 18 parts of CitrusaurantiumL.Var.amara Engl.s, 19 parts of Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), 17 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 18 parts of Pericarpium Citri Reticulataes, 19 parts in Poria, 18 parts of Radix Glycyrrhizae Preparatas, 8 parts of Fructus Aurantii Immaturuss, 18 parts of Radix puerariae roots, 18 parts of Radix Salviae Miltiorrhizae, 20 parts of Ramulus Uncariae macrophyllae, 18 parts of Magnetitum, content are 20 parts of 97% edible ethanols.Other is identical with embodiment 1.
Claims (5)
1. the medicine that treatment is dizzy is characterized in that it mainly is to be made by the raw material of following weight portion: 1 ~ 20 part of Flos Rosae Rugosae, 1 ~ 20 part of CitrusaurantiumL.Var.amara Engl., 1 ~ 20 part of Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), 1 ~ 20 part of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), 1 ~ 20 part of Pericarpium Citri Reticulatae, 1 ~ 20 part in Poria, 1 ~ 20 part of Radix Glycyrrhizae Preparata, 1 ~ 20 part of Fructus Aurantii Immaturus, 1 ~ 20 part of Radix puerariae root, 1 ~ 20 part of Radix Salviae Miltiorrhizae, 1 ~ 20 part of Ramulus Uncariae macrophyllae, 1 ~ 20 part of Magnetitum, content are 1 ~ 20 part of edible ethanol more than 95%.
2. medicine as claimed in claim 1 is characterized in that it mainly is to be made by the raw material of following weight portion: 15 ~ 20 parts of Flos Rosae Rugosaes, 15 ~ 20 parts of CitrusaurantiumL.Var.amara Engl.s, 15 ~ 20 parts of Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), 15 ~ 20 parts of Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens)s, 15 ~ 20 parts of Pericarpium Citri Reticulataes, 15 ~ 20 parts in Poria, 15 ~ 20 parts of Radix Glycyrrhizae Preparatas, 5 ~ 10 parts of Fructus Aurantii Immaturuss, 15 ~ 20 parts of Radix puerariae roots, 15 ~ 20 parts of Radix Salviae Miltiorrhizae, 15 ~ 20 parts of Ramulus Uncariae macrophyllae, 15 ~ 20 parts of Magnetitum, content are 15 ~ 20 parts of edible ethanols more than 95%.
3. medicine as claimed in claim 1 or 2 is characterized in that described medicine comprises that also weight portion is 1 ~ 5 part a azone.
4. the preparation method of the described medicine of one of claim 1 to 3 is characterized in that comprising the following steps:
A) take by weighing Flos Rosae Rugosae, CitrusaurantiumL.Var.amara Engl., Caulis Bambusae In Taenia (processed with Rhizoma Zingiberis Recens), Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens), Pericarpium Citri Reticulatae, Poria, Radix Glycyrrhizae Preparata, Fructus Aurantii Immaturus, Radix puerariae root, Radix Salviae Miltiorrhizae, Ramulus Uncariae macrophyllae and the Magnetitum of described weight proportion, according to the conventional extracting method of Chinese medicine, the extract of the former medicine that obtains respectively respectively to distinguish the flavor of;
B) under the room temperature, get the deionized water of 5 ~ 6 times of amounts, the content that adds described weight proportion is the edible ethanol more than 95%, is mixed with aqueous solution of alcohol;
C) with in the above-mentioned aqueous solution of alcohol of the extract obtained adding of step a, stirred 120 minutes, precipitate 2 ~ 4 hours, filter, gained filtrate sterilization, fill according to quantity must be treated dizzy medicine.
5. preparation method as claimed in claim 4 is characterized in that, among the step c, azone step a is extract obtained and described weight proportion adds aqueous solution of alcohol together.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102646513A CN101912547B (en) | 2010-08-27 | 2010-08-27 | Medicament for treating dizziness and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102646513A CN101912547B (en) | 2010-08-27 | 2010-08-27 | Medicament for treating dizziness and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101912547A true CN101912547A (en) | 2010-12-15 |
| CN101912547B CN101912547B (en) | 2012-06-20 |
Family
ID=43320294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102646513A Expired - Fee Related CN101912547B (en) | 2010-08-27 | 2010-08-27 | Medicament for treating dizziness and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101912547B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102283964A (en) * | 2011-09-07 | 2011-12-21 | 中国人民解放军第三七一医院 | Chinese medicinal preparation for treating vertigo |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101130054A (en) * | 2007-09-14 | 2008-02-27 | 尹克华 | Traditional Chinese medicine for treating essential resistance of turbid phlegm type vertigo |
-
2010
- 2010-08-27 CN CN2010102646513A patent/CN101912547B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101130054A (en) * | 2007-09-14 | 2008-02-27 | 尹克华 | Traditional Chinese medicine for treating essential resistance of turbid phlegm type vertigo |
Non-Patent Citations (1)
| Title |
|---|
| 《中医药信息》 20001231 陈浙鲁 竹茹的五种炮制品和临床应用 第36页 1-5 , 第5期 2 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102283964A (en) * | 2011-09-07 | 2011-12-21 | 中国人民解放军第三七一医院 | Chinese medicinal preparation for treating vertigo |
| CN102283964B (en) * | 2011-09-07 | 2013-06-12 | 中国人民解放军第三七一医院 | Chinese medicinal preparation for treating vertigo |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101912547B (en) | 2012-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103550495B (en) | A kind of Chinese medicine composition of Cure for insomnia | |
| CN103007190A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN101972446B (en) | Medicament for treating coronary disease and preparation method thereof | |
| CN101912597A (en) | Medicament for treating senile dementia and preparation method thereof | |
| CN101912548B (en) | Medicament for treating nocturnal fretfulness infants and preparation method thereof | |
| CN101983689B (en) | Drug for treating prostatitis and preparation method thereof | |
| CN101912596B (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN101904985B (en) | Medicament for treating skin itch and preparation method thereof | |
| CN103550688B (en) | A kind of Chinese medicine composition for the treatment of cardiopalmus | |
| CN101987156B (en) | Medicine for treating toothache and preparation method thereof | |
| CN101912498B (en) | Medicament for treating gout and preparation method thereof | |
| CN101912547B (en) | Medicament for treating dizziness and preparation method thereof | |
| CN102327410B (en) | Traditional Chinese medicine composition for treating epigastric fullness | |
| CN105963505A (en) | Traditional Chinese medicinal foot bath powder capable of treating insomnia | |
| CN101856476A (en) | Chinese medicament for treating stomachache | |
| CN104758674A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN104606469A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN104666689A (en) | Medicine for treating hypertension | |
| CN101912584A (en) | Medicine for treating melancholia and preparation method thereof | |
| CN115252700B (en) | Traditional Chinese medicine composition and medicine for treating cervical tinnitus and preparation method thereof | |
| CN101244194B (en) | Chinese medicine for treating scrofula disease | |
| CN102188675B (en) | Medicine for treating peripheral vertigo, and preparation thereof | |
| CN101987136B (en) | Medicine for treating neurodermatitis and preparation method thereof | |
| CN105727000B (en) | Chinese medicine composition and the application in vertebral artery type of cervical spondylosis treatment | |
| CN101972399B (en) | Medicament for treating hypertension and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120620 Termination date: 20180827 |